1,629
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 109-135 | Received 30 Jul 2023, Accepted 10 Nov 2023, Published online: 19 Jan 2024

References

  • Goldenson J, Kitollari I, Lehman F. The relationship between ACEs, trauma-related psychopathology and resilience in vulnerable youth: implications for screening and treatment. J Child Adol Trauma. 2021;14(1):151–160. doi:10.1007/s40653-020-00308-y
  • Roberts NP, Back SE, Mueser KT, Murray LK. Treatment considerations for PTSD comorbidities. In: Forbes D, Bisson JI, Monson CM, Berliner L, editors. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. The Guilford Press; 2020:417–450.
  • Solomon SD, Davidson JR. Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry. 1997;58(9):5–11.
  • Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry. 2000;61:4–14.
  • Watson P. PTSD as a public mental health priority. Curr Psychiatry Rep. 2019;21(7):1–12. doi:10.1007/s11920-019-1032-1
  • Cukor J, Olden M, Lee F, Difede J. Evidence-based treatments for PTSD, new directions, and special challenges. AnN N Y Acad Sci. 2010;1208:82–89. doi:10.1111/j.1749-6632.2010.05793.x
  • Ipser JC, Stein DJ. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012;15(6):825–840. doi:10.1017/S1461145711001209
  • Schnurr PP. Focusing on trauma-focused psychotherapy for posttraumatic stress disorder. Curr Opin Psychol. 2017;14:56–60. doi:10.1016/j.copsyc.2016.11.005
  • Burback L, Brémault-Phillips SNJM, McFarlane A, Vermetten E. Treatment of posttraumatic stress disorder: a state-of-the-art review. Curr Neuropharmacol. 2023;21. doi:10.2174/1570159X21666230428091433
  • Leichsenring F, Steinert C, Rabung S, Ioannidis JPA. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry. 2022;21(1):133–145. doi:10.1002/wps.20941
  • Najavits LM. The problem of dropout from “gold standard PTSD therapies. F1000prime Rep. 2015;7. doi:10.12703/P7-43
  • Black TG. Psychotherapy and outcome research in PTSD: understanding the challenges and complexities in the literature. Can J Counselling Psychothera. 2004;38(4):277–287.
  • Nottingham N, Chadwick C. Conceptualizing a new definition of patient burden. Ann Fam Med. 2022;20(1):2772.
  • Reeves R. A synthesis of the literature on trauma-informed care. Issues Ment Health Nurs. 2015;36(9):698–709. doi:10.3109/01612840.2015.1025319
  • Krystal JH, Davis LL, Neylan TC, et al. It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group. Biol Psychiatry. 2017;82(7):e51–e59. doi:10.1016/j.biopsych.2017.03.007
  • Howes OD, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry. 2022;27(1):58–72. doi:10.1038/s41380-021-01200-3
  • Galvão-Coelho NL, Marx W, Gonzalez M. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. Psychopharmacology. 2021;238(2):341–354. doi:10.1007/s00213-020-05719-1
  • Goodwin GM, Aaronson ST, Alvarez O, et al. Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life. J Affect Disord. 2023;327:120–127. doi:10.1016/j.jad.2023.01.108
  • Ko K, Kopra EI, Cleare AJ, Rucker JJ. Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis. J Affect Disord. 2023;322:194–204. doi:10.1016/j.jad.2022.09.168
  • Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled Phase 3 study. Nat Med. 2021;27(6):1025–1033. doi:10.1038/s41591-021-01336-3
  • Zeifman RJ, Yu D, Singhal N, Wang G, Nayak SM, Weissman CR. Decreases in suicidality following psychedelic therapy: a meta-analysis of individual patient data across clinical trials. J Clin Psychiatry. 2022;83(2):39235.
  • Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB. Must psilocybin always assist psychotherapy? Am J Psychiatry. 2023. doi:10.1176/appi.ajp.20221043
  • Mithoefer MC. Manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder; 2015.
  • Nutt D. Psychedelic drugs—a new era in psychiatry? Dialogues Clin Neurosci. 2019;21(2):139–147. doi:10.31887/DCNS.2019.21.2/dnutt
  • Schenberg EE. Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development. Front Pharmacol. 2018;9:733. doi:10.3389/fphar.2018.00733
  • Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review. Neurosci Biobehav Rev. 2022;140:104793. doi:10.1016/j.neubiorev.2022.104793
  • Breeksema JJ, Kuin BW, Kamphuis J, Brink W, Vermetten E, Schoevers RA. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: a mixed-methods systematic review. J Psychopharmacol. 2022;36(10):1100–1117. doi:10.1177/02698811221116926
  • Banks MI, Zahid Z, Jones NT, Sultan ZW, Wenthur CJ. Catalysts for change: the cellular neurobiology of psychedelics. Mol Biol Cell. 2021;32(12):1135–1144. doi:10.1091/mbc.E20-05-0340
  • Vollenweider FX, Preller KH. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosci. 2020;21(11):611–624. doi:10.1038/s41583-020-0367-2
  • Nutt D, Spriggs M, Erritzoe D. Psychedelics therapeutics: what we know, what we think, and what we need to research. Neuropharmacology. 2023;223:109257. doi:10.1016/j.neuropharm.2022.109257
  • Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Development of the psychological insight questionnaire among a sample of people who have consumed psilocybin or LSD. J Psychopharmacol. 2021;35(4):437–446. doi:10.1177/0269881120967878
  • Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R. Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory. J Psychopharmacol. 2019;33(9):1076–1087. doi:10.1177/0269881119855974
  • Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, mystical experience, and therapeutic efficacy: a systematic review. Front Psychiatry. 2022;13:917199. doi:10.3389/fpsyt.2022.917199
  • Carhart-Harris RL, Roseman L, Haijen E, et al. Psychedelics and the essential importance of context. J Psychopharmacol. 2018;32(7):725–731. doi:10.1177/0269881118754710
  • Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008;22(6):603–620. doi:10.1177/0269881108093587
  • Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies. CNS Drugs. 2020;34(9):925–946. doi:10.1007/s40263-020-00748-y
  • Crowe M, Manuel J, Carlyle D, Lacey C. Experiences of psilocybin treatment for clinical conditions: a qualitative meta-synthesis. Int J Mental Health Nurs. 2023;32(1):1–13. doi:10.1111/inm.13110
  • Barone W, Beck J, Mitsunaga-Whitten M, Perl P. Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD. J Psychoactive Drugs. 2019;51(2):199–208. doi:10.1080/02791072.2019.1580805
  • McFarlane AC, Yehuda R. Clinical treatment of posttraumatic stress disorder: conceptual challenges raised by recent research. Aust N Z J Psychiatry. 2000;34(6):940–953. doi:10.1080/000486700268
  • Borissova A, Rucker J. The development of psilocybin therapy for treatment-resistant depression: an update. BJPsych Bulletin. 2023;1–7. doi:10.1192/bjb.2023.25
  • Eisenstein M. The psychedelic escape from depression. Nature. 2022;609(7929):87–89. doi:10.1038/d41586-022-02872-9
  • Kisely S. The down-scheduling of MDMA and psilocybin(e): too fast and too soon. Aust N Z J Psychiatry. 2023;57(7):933–934. doi:10.1177/00048674231174171
  • Angelo FN, Miller HE, Zoellner LA, Feeny NC. I need to talk about it: a qualitative analysis of trauma-exposed women’s reasons for treatment choice. Behav Ther. 2008;39(1):13–21. doi:10.1016/j.beth.2007.02.002
  • Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. Organ Res Methods. 2008;12(3):614–617.
  • Sutton J, Austin Z. Qualitative research: data collection, analysis, and management. Can J Hosp Pharm. 2015;68(3):226–231. doi:10.4212/cjhp.v68i3.1456
  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;88:n71.
  • Anonymous. 2022. Critical Appraisal Skills Programme.
  • Shearing V, Lee V, Clohessy S. How do clients experience reliving as part of trauma-focused cognitive behavioural therapy for posttraumatic stress disorder. Psychol Psychother. 2011;84(4):458–475. doi:10.1111/j.2044-8341.2010.02012.x
  • Woodhouse S, Ayers S, Field AP. The relationship between adult attachment style and post-traumatic stress symptoms: a meta-analysis. J. Anxiety Disord. 2015;35:103–117. doi:10.1016/j.janxdis.2015.07.002
  • Lowe C, Murray C. Adult service-users’ experiences of trauma-focused cognitive behavioural therapy. J Contemp Psychother. 2014;44:223–231.
  • Mott JM, Sutherland RJ, Williams W, Lanier SH, Ready DJ, Teng EJ. Patient perspectives on the effectiveness and tolerability of group-based exposure therapy for posttraumatic stress disorder: preliminary self-report findings from 20 veterans. Psychol Trauma. 2013;5(5):453. doi:10.1037/a0029386
  • Murray H, Merritt C, Grey N. Clients’ experiences of returning to the trauma site during PTSD treatment: an exploratory study. Behav Cognitive Psychother. 2016;44(4):420–430. doi:10.1017/S1352465815000338
  • Favaretto TC, Both LM, Benetti SPDC, Freitas LHM. Relationship between psychodynamic functioning, defensive mechanisms and trauma in patients with PTSD?. Trends Psychiatry Psychother. 2023. Available from: 10.47626/2237-6089-2022-0546. Accessed December 28, 2023.
  • Sripada RK, Walters HM. ‘I wish people could come together like we have,’patient and provider perspectives on VA residential PTSD treatment. Psychological Services. 2022;20(4). Available from: https://web.s.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&db=pdh&jrnl=15411559&asa=N&AN=2023-03399-001&h=J2tBOgVg9NW7mNoOYNjTFa1rZ%2bv7RX1%2b6r5h637UbRrhb6U6N7Ey%2fVLdiI3%2bk7BoL1uvCuKKsy2VQV8rp38G3Q%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26db%3dpdh%26jrnl%3d15411559%26asa%3dN%26AN%3d2023-03399-001. Accessed December 28, 2023.
  • Watts R, Day C, Krzanowski J, Nutt D, Carhart-Harris R. Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. J Humanistic Psychol. 2017;57(5):520–564. doi:10.1177/0022167817709585
  • Moreton SG, Szalla L, Menzies RE, Arena AF. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology. 2020;237(1):21–32. doi:10.1007/s00213-019-05391-0
  • Fauvel B, Strika-Bruneau L, Piolino P. Changes in self-rumination and self-compassion mediate the effect of psychedelic experiences on decreases in depression, anxiety, and stress. Psychol Consciousness. 2021;10(1):88–102.
  • Krediet E, Bostoen T, Breeksema J, Schagen A, Passie T, Vermetten E. Reviewing the potential of psychedelics for the treatment of PTSD. Int J Neuropsychopharmacol. 2020;23(6):385–400. doi:10.1093/ijnp/pyaa018
  • Bird CIV, Modlin NL, Rucker JJH. Psilocybin and MDMA for the treatment of trauma-related psychopathology. Int Rev Psychiatry. 2021;33(3):229–249. doi:10.1080/09540261.2021.1919062
  • Howard R, Berry K, Haddock G. Therapeutic alliance in psychological therapy for posttraumatic stress disorder: a systematic review and meta‐analysis. Clin Psychol Psychother. 2022;29(2):373–399. doi:10.1002/cpp.2642
  • Safran JD, Muran JC. The resolution of ruptures in the therapeutic alliance. J Consul Clin Psychol. 1996;64(3):447–458. doi:10.1037/0022-006X.64.3.447
  • Brown LA, Belli GM, Asnaani A. A review of the role of negative cognitions about oneself, others, and the world in the treatment of PTSD. Cogn Ther Res. 2019;43:43143–43173.
  • Crespo M, Fernández-Lansac V. Memory and narrative of traumatic events: a literature review. Psychological Trauma. 2016;8(2):149. doi:10.1037/tra0000041
  • Ranjbar N, Erb M, Mohammad O, Moreno FA. Trauma-Informed Care and Cultural Humility in the Mental Health Care of People from Minoritized Communities. Vol. 18. Focus (American Psychiatric Publishing); 2020.
  • Ginot E. Self-narratives and dysregulated affective states: the neuropsychological links between self-narratives, attachment, affect, and cognition. Psychoanal Psychol. 2012;29(1):59. doi:10.1037/a0023154
  • Zeifman R, Spriggs M, Kettner H, et al. From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): preliminary development of the relaxed beliefs questionnaire (reb-q). Sci Rep. 2022. Available from: https://spiral.imperial.ac.uk/handle/10044/1/102760. Accessed December 28, 2023.
  • Modlin NL, Stubley J, Maggio C, Rucker JJ. On redescribing the indescribable: trauma, psychoanalysis and psychedelic therapy. Br J Psychother. 2023;39(3):551–572. doi:10.1111/bjp.12852
  • Villiger D, Trachsel M. With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis. J Med Ethics. 2023;49(12):826–832. doi:10.1136/jme-2022-108816
  • Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM. The need for establishing best practices and gold standards in psychedelic medicine. J Affect Disord. 2023;332:47–54. doi:10.1016/j.jad.2023.03.083
  • Wells SY, Morland LA, Hurst S, et al. Veterans’ reasons for dropping out of prolonged exposure therapy across three delivery modalities: a qualitative examination. Psychol Serv. 2023;20(3):483. doi:10.1037/ser0000714
  • Johansen L, Liknaitzky P, Nedeljkovic M. The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol. Syst Rev. 2022;11:85.
  • Varker T, Watson L, Gibson K, Knight H, O’Donnell M. Hallucinogens as Treatments for PTSD, Anxiety and Depression: A Rapid Evidence Assessment. Report Prepared for the Department of Veterans’ Affairs. Phoenix Australia Centre for Posttraumatic Mental Health; 2017.
  • Sweeney A, Taggart D. Understanding trauma-informed approaches in mental health. J Mental Health. 2018;27(5):383–387. doi:10.1080/09638237.2018.1520973
  • Gukasyan N, Nayak SM. Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy. Transcult Psychiatry. 2022;59(5):652–664. doi:10.1177/1363461520983684
  • Williamson V, Murphy D, Phelps A, Forbes D, Greenberg N. Moral injury: the effect on mental health and implications for treatment. Lancet Psychiatry. 2021;8(6):453–455. doi:10.1016/S2215-0366(21)00113-9
  • L WD. Information processing bias in post-traumatic stress disorder. Open Neuroimaging J. 2008;2:229–251.
  • Abramson HA. LSD in psychotherapy and alcoholism. Am J Psychother. 1966;20(3):415–438. doi:10.1176/appi.psychotherapy.1966.20.3.415
  • Ogrodniczuk JS, Joyce AS, Piper WE. Development of the readiness for psychotherapy index. J Nerv Ment Dis. 2009;197(6):427–433. doi:10.1097/NMD.0b013e3181a61c56
  • Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(8):45. doi:10.1186/1471-2288-8-45
  • Meis LA, Polusny MA, Kehle-Forbes SM, et al. Making sense of poor adherence in PTSD treatment from the perspectives of veterans and their therapists. Psychol Trauma. 2023;15(4):715. doi:10.1037/tra0001199
  • Sherrill AM, Maples-Keller JL, Yasinski CW, Loucks LA, Rothbaum BO, Rauch SA. Perceived benefits and drawbacks of massed prolonged exposure: a qualitative thematic analysis of reactions from treatment completers. Psychol Trauma. 2022;14(5):862. doi:10.1037/tra0000548
  • Borges LM, Bahraini NH, Holliman BD, Gissen MR, Lawson WC, Barnes SM. Veterans’ perspectives on discussing moral injury in the context of evidence‐based psychotherapies for PTSD and other VA treatment. J Clin Psychol. 2020;76(3):377–391. doi:10.1002/jclp.22887
  • Matheson C, Weightman E. A participatory study of patient views on psychotherapy for complex post-traumatic stress disorder, CPTSD. J Ment Health. 2021;30(6):690–697. doi:10.1080/09638237.2020.1803229
  • Sandberg J, Gustafsson S, Holmqvist R. Interpersonally traumatised patients’ view of significant and corrective experiences in the psychotherapeutic relationship. Eur J Psychother Counselling. 2017;19(2):175–199. doi:10.1080/13642537.2017.1313881
  • Vincent F, Jenkins H, Larkin M, Clohessy S. Asylum-seekers’ experiences of trauma-focused cognitive behaviour therapy for post-traumatic stress disorder: a qualitative study. Behav Cognitive Psychother. 2013;41(5):579–593. doi:10.1017/S1352465812000550
  • Thoresen IH, Auren TJB, Langvik EO, Engesæth C, Jensen AG, Klæth JR. Intensive outpatient treatment for post-traumatic stress disorder: a thematic analysis of patient experience. Eur J Psychotraumatol. 2022;13(1):2043639. doi:10.1080/20008198.2022.2043639
  • Boterhoven de Haan KL, Lee CW, Correia H, et al. Patient and therapist perspectives on treatment for adults with PTSD from childhood trauma. J Clin Med. 2021;10(5):954. doi:10.3390/jcm10050954
  • Hundt NE, Ecker AH, Thompson K, et al. “It didn’t fit for me:” A qualitative examination of dropout from prolonged exposure and cognitive processing therapy in veterans. Psychol Serv. 2020;17(4):414. doi:10.1037/ser0000316
  • Booysen DD, Kagee A. Trauma survivors’ perceptions and experiences of prolonged exposure for PTSD at a psychology clinic. South Af J Psychiatry. 2023;29:1869. doi:10.4102/sajpsychiatry.v29i0.1869
  • Hundt NE, Barrera TL, Arney J, Stanley MA. “It’s worth it in the end”: veterans’ experiences in prolonged exposure and cognitive processing therapy. Cogn Behav Pract. 2017;24(1):50–57. doi:10.1016/j.cbpra.2016.02.003
  • Harned MS, Schmidt SC. Perspectives on a stage-based treatment for posttraumatic stress disorder among dialectical behavior therapy consumers in public mental health settings. Community Ment Health J. 2019;55(3):409–419. doi:10.1007/s10597-018-0358-1
  • Kehle-Forbes SM, Ackland PE, Spoont MR, et al. Divergent experiences of US veterans who did and did not complete trauma-focused therapies for PTSD: a national qualitative study of treatment dropout. Behav Res Ther. 2022;154:104123. doi:10.1016/j.brat.2022.104123
  • Zielinski MJ, Karlsson ME, Bridges AJ. “I’m not alone, my story matters”: incarcerated women’s perspectives on the impact and acceptability of group psychotherapy involving imaginal exposure to sexual assault memories. Health Justice. 2021;9:1–14. doi:10.1186/s40352-021-00148-4
  • Andersen MR, Clausen A, Nielsen ABS, Svendsen ALH. Experiences with basic body awareness therapy as an add-on to cognitive behavioural therapy among Danish military veterans with PTSD: an interview study. J Bodywork Bodywork Ther. 2021;27:550–559. doi:10.1016/j.jbmt.2021.03.023
  • van Gelderen MJ, Nijdam MJ, Dubbink GE, Sleijpen M, Vermetten E. Perceived treatment processes and effects of interactive motion-assisted exposure therapy for veterans with treatment-resistant posttraumatic stress disorder: a mixed methods study. Eur J Psychotraumatol. 2020;11(1):1829400. doi:10.1080/20008198.2020.1829400
  • Cook JM, Simiola V, Hamblen JL, Bernardy N, Schnurr PP. The influence of patient readiness on implementation of evidence-based PTSD treatments in Veterans Affairs residential programs. Psychol Trauma. 2017;9(Suppl 1):51–58. doi:10.1037/tra0000162
  • Murray H, Grey N, Warnock-Parkes E, et al. Ten misconceptions about trauma-focused CBT for PTSD. Cognitive Behav Therapist. 2022;15:33. doi:10.1017/S1754470X22000307
  • Cook SC, Schwartz AC, Kaslow NJ. Evidence-based psychotherapy: advantages and challenges. Neurotherapeutics. 2017;14(3):537–545. doi:10.1007/s13311-017-0549-4
  • Hegarty S, Ehntholt K, Williams D, Kennerley H, Billings J, Bloomfield M. Acceptability and mechanisms of change associated with group cognitive behavioural therapy using the recovering from childhood abuse programme among women with CPTSD: a qualitative analysis. Cognitive Behav Therapist. 2022;15:e46. doi:10.1017/S1754470X2200037X
  • Jackson KT, Mantler T, Jackson B, Walsh EJ, Baer J, Parkinson S. Exploring mothers’ experiences of trauma and violence-informed cognitive behavioural therapy following intimate partner violence: a qualitative case analysis. J Psychosomatic Obstet Gynecol. 2020;41(4):308–316. doi:10.1080/0167482X.2019.1707799
  • Price JL, MacDonald HZ, Adair KC, Koerner N, Monson CM. Changing beliefs about trauma: a qualitative study of cognitive processing therapy. Behav Cognitive Psychother. 2016;44(2):156–167. doi:10.1017/S1352465814000526
  • Grailey KE, Murray E, Reader T, Brett SJ. The presence and potential impact of psychological safety in the healthcare setting: an evidence synthesis. BMC Health Serv Res. 2021;21(1):773. doi:10.1186/s12913-021-06740-6
  • Hunt DF, Bailey J, Lennox BR, Crofts M, Vincent C. Enhancing psychological safety in mental health services. Int J Mental Health Syst. 2021;15(1):33. doi:10.1186/s13033-021-00439-1
  • Crits-Christoph P, Rieger A, Gaines A, Gibbons MBC. Trust and respect in the patient-clinician relationship: preliminary development of a new scale. BMC Psychol. 2019;7(1):91. doi:10.1186/s40359-019-0347-3
  • DePrince AP, Brown LS, Cheit RE, et al. Motivated forgetting and misremembering: perspectives from betrayal trauma theory. True False Recovered Memories. 2012;2012:193–242.
  • Smith CP, Freyd JJ. Insult, then injury: interpersonal and institutional betrayal linked to health and dissociation. J Aggression Maltreat Trauma. 2017;26(10):1117–1131. doi:10.1080/10926771.2017.1322654
  • Agin-Liebes G, Ekman E, Anderson B, Malloy M, Haas A, Woolley J. Participant reports of mindfulness, posttraumatic growth, and social connectedness in psilocybin-assisted group therapy: an interpretive phenomenological analysis. J Humanistic Psychol. 2021;58:00221678211022949.
  • Agin-Liebes G, Nielson EM, Zingman M, et al. Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: an interpretive phenomenological analysis. Psychol Addict Behav. 2023. doi:10.1037/adb0000935
  • Belser AB, Agin-Liebes G, Swift TC, et al. Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis. J Humanistic Psychol. 2017;57(4):354–388. doi:10.1177/0022167817706884
  • Camlin TJ, Eulert D, Thomas Horvath A, Bucky SF, Barsuglia JP, Polanco M. A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders. J Psychedelic Stud. 2018;2(1):24–35. doi:10.1556/2054.2018.004
  • Gasser P, Kirchner K, Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol. 2015;29(1):57–68. doi:10.1177/0269881114555249
  • Malone TC, Mennenga SE, Guss J, et al. Individual experiences in four cancer patients following psilocybin-assisted psychotherapy. Front Pharmacol. 2018;9:256. doi:10.3389/fphar.2018.00256
  • Mollaahmetoglu OM, Keeler J, Ashbullby KJ, Ketzitzidou-Argyri E, Grabski M, Morgan CJ. “This is something that changed my life”: a qualitative study of patients’ experiences in a clinical trial of ketamine treatment for alcohol use disorders. Front Psychiatry. 2021;12:695335. doi:10.3389/fpsyt.2021.695335
  • Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts. J Psychopharmacol. 2018;32(7):756–769. doi:10.1177/0269881118780612
  • Schenberg EE, de Castro Comis MA, Alexandre JFM, Chaves BDR, Tófoli LF, da Silveira DX. Treating drug dependence with the aid of ibogaine: a qualitative study. J Psychedelic Stud. 2017;1(1):10–19. doi:10.1556/2054.01.2016.002
  • Schenberg EE, de Castro Comis MA, Alexandre JFM, Tófoli LF, Chaves BDR, da Silveira DX. A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment. J Psychedelic Stud. 2017;1(2):74–83. doi:10.1556/2054.01.2017.007
  • Swift TC, Belser AB, Agin-Liebes G, et al. Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. J Humanistic Psychol. 2017;57(5):488–519. doi:10.1177/0022167817715966
  • Hayes SC, Law S, Malady M, Zhu Z, Bai X. The centrality of sense of self in psychological flexibility processes: what the neurobiological and psychological correlates of psychedelics suggest. J Contextual Behav Sci. 2020;15:30–38. doi:10.1016/j.jcbs.2019.11.005
  • Yaden DB, Griffiths RR. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol Transl. 2020;4(2):568–572. doi:10.1021/acsptsci.0c00194
  • Jungaberle H, Thal S, Zeuch A, et al. Positive psychology in the investigation of psychedelics and entactogens: a critical review. Neuropharmacology. 2018;142:179–199. doi:10.1016/j.neuropharm.2018.06.034
  • Teixeira PJ, Johnson MW, Timmermann C, et al. Psychedelics and health behaviour change. J Psychopharmacol. 2022;36(1):12–19. doi:10.1177/02698811211008554
  • Dajani DR, Uddin LQ. Demystifying cognitive flexibility: implications for clinical and developmental neuroscience. Trends Neurosci. 2015;38(9):571–578. doi:10.1016/j.tins.2015.07.003
  • Nielson EM, May DG, Forcehimes AA, Bogenschutz MP. The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions. Front Pharmacol. 2018;9:132. doi:10.3389/fphar.2018.00132
  • Kaplan MJ, Klinetob NA. Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. J Nerv Ment Dis. 2000;188(9):596–601. doi:10.1097/00005053-200009000-00006
  • Williams L, Debattista C, Duchemin AM. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Transl Psychiatry. 2016;6(5):799. doi:10.1038/tp.2016.61
  • Elsouri KN, Kalhori S, Colunge D, et al. Psychoactive drugs in the management of post traumatic stress disorder: a promising new horizon. Cureus. 2022;14(5):25235.
  • Kočárová R, Horáček J, Carhart-Harris R. Does psychedelic therapy have a transdiagnostic action and prophylactic potential?. Front Psychiatry. 2021;12:661233. doi:10.3389/fpsyt.2021.661233
  • Butler LD, Critelli FM, Rinfrette ES. Trauma-informed care and mental health. Directions Psychiatry. 2011;31(3):197–212.
  • Anonymous. Substance Abuse and Mental Health Services Administration: Practical Guide for Implementing a Trauma-Informed Approach. SAMHSA Publication; 2023.
  • Kendler K. A history of the DSM-5 scientific review committee. Psychol. Med. 2013;43(9):1793–1800. doi:10.1017/S0033291713001578
  • Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW. Psychedelics and psychotherapy: cognitive-behavioral approaches as default. Front Psychol. 2022;13:873279. doi:10.3389/fpsyg.2022.873279
  • Burton J, Ratner A, Cooper T, Guss J. Commentary: psychedelics and psychotherapy: cognitive-behavioral approaches as default. Front Psychol. 2022;13:6261.
  • Freyd JJ. What is a betrayal trauma? What is betrayal trauma theory? 2003. Available from: http://dynamic.uoregon.edu/~jjf/defineBT.html. Accessed December 28, 2023.
  • Smith CP, Freyd JJ. Institutional betrayal. Am. Psychol. 2014;69(6):575. doi:10.1037/a0037564
  • Sweeney A, Filson B, Kennedy A, Collinson L, Gillard S. A paradigm shift: relationships in trauma-informed mental health services. BJPsych Adv. 2018;24(5):319–333. doi:10.1192/bja.2018.29
  • Purkey E, Patel R, Phillips SP. Trauma-informed care: better care for everyone. Can Fam Physician. 2018;64(3):170–172.
  • Diener MJ, Monroe JM. The relationship between adult attachment style and therapeutic alliance in individual psychotherapy: a meta-analytic review. Psychotherapy. 2011;48(3):237. doi:10.1037/a0022425
  • Rubino G, Barker C, Roth T, Fearon P. Therapist empathy and depth of interpretation in response to potential alliance ruptures: the role of therapist and patient attachment styles. Psychother Res. 2000;10(4):408–420. doi:10.1093/ptr/10.4.408
  • Meyer B, Pilkonis PA. Attachment style. Psychotherapy. 2001;38(4):466. doi:10.1037/0033-3204.38.4.466
  • Murphy R, Kettner H, Zeifman R, et al. Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression. Front Pharmacol. 2022;12:788155. doi:10.3389/fphar.2021.788155
  • Anonymous compass ACNP pathway analysis[online]. Available from: https://compasspathways.com/wp-content/uploads/2022/11/COMPASS_ACNP_PathAnalysis.pdf. Accessed July 10, 2023.
  • Kornhaber R, Walsh K, Duff J, Walker K. Enhancing adult therapeutic interpersonal relationships in the acute health care setting: an integrative review. J Multidisciplinary Healthcare. 2016;2016:9537–9546.
  • Thal S, Engel LB, Bright SJ. Presence, trust, and empathy: preferred characteristics of psychedelic carers. J Humanistic Psychol. 2022;002216782210813. doi:10.1177/00221678221081380
  • Coutinho J, Ribeiro E, Hill C, Safran J. Therapists’ and clients’ experiences of alliance ruptures: a qualitative study. Psychother Res. 2011;21(5):525–540. doi:10.1080/10503307.2011.587469
  • Larsson MH, Falkenström F, Andersson G, Holmqvist R. Alliance ruptures and repairs in psychotherapy in primary care. Psychother Res. 2018;28(1):123–136. doi:10.1080/10503307.2016.1174345
  • S LM. A helpful way to conceptualize and understand reenactments. J Psychother Pract Res. 1998;7(3):227–235.
  • Yoo Y, Park H, Park S, Cho MJ, Cho S, Lee JY. Interpersonal trauma moderates the relationship between personality factors and suicidality of individuals with posttraumatic stress disorder. PLoS One. 2018;13(1):0191198. doi:10.1371/journal.pone.0191198
  • Maggio C, Fischer FM, Modlin NL, Rucker J. Psychoanalytic formulations in psychedelic therapy for Treatment Resistant Depression (TRD). J Psychol Psychother. 2023;13:451.
  • Byrne P. Psychiatric stigma. Br J Psychiatry. 2001;178(3):281–284. doi:10.1192/bjp.178.3.281
  • Butler M, Jelen L, Rucker J. Expectancy in placebo-controlled trials of psychedelics: if so, so what?. Psychopharmacology. 2022;239(10):3047–3055. doi:10.1007/s00213-022-06221-6
  • Berkout OV. Working with values: an overview of approaches and considerations in implementation. Behav Anal Pract. 2021;15(1):104–114. doi:10.1007/s40617-021-00589-1
  • Neimeyer R. Meaning reconstruction in the wake of loss: evolution of a research program. Behav Change. 2016;33(2):65–79. doi:10.1017/bec.2016.4
  • Ross S, Agrawal M, Griffiths RR, Grob C, Berger A, Henningfield JE. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care. Neuropharmacology. 2022;216:109174. doi:10.1016/j.neuropharm.2022.109174
  • Serfioti D, Murphy D, Greenberg N, Williamson V. Professionals’ perspectives on relevant approaches to psychological care in moral injury: a qualitative study. J Clin Psychol. 2023;79(10):2404–2421. doi:10.1002/jclp.23556
  • Thal SB, Bright SJ, Sharbanee JM, Wenge T, Skeffington PM. Current perspective on the therapeutic preset for substance-assisted psychotherapy. Front Psychol. 2021;12:617224. doi:10.3389/fpsyg.2021.617224
  • He Q, Veldkamp BP, Vries T. Screening for posttraumatic stress disorder using verbal features in self narratives: a text mining approach. Psychiatry Res. 2012;198(3):441–447. doi:10.1016/j.psychres.2012.01.032
  • Jaeger J, Lindblom KM, Parker-Guilbert K, Zoellner LA. Trauma narratives: it’s what you say, not how you say it. Psychological Trauma. 2014;6(5):473–481. doi:10.1037/a0035239
  • Dimaggio G, Salvatore G, Azzara C, Catania D. Rewriting self narratives: the therapeutic process. J Constr Psychol. 2003;16(2):155–181. doi:10.1080/10720530390117920
  • Harris M, Fallot R. Using Trauma Theory to Design Service Systems. New Directions for Mental Health Services. San Francisco, CA: Jossey-Bass; 2001.
  • Bender D, Hellerstein DJ. Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research. Psychopharmacology. 2022;239(6):1907–1932. doi:10.1007/s00213-021-06049-6
  • Nour MM, Evans L, Nutt D, Carhart-Harris RL. Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum. 2016;10:269.
  • Hook J, Devereux D. Boundary violations in therapy: the patient’s experience of harm. BJPsych Adv. 2018;24(6):366–373. doi:10.1192/bja.2018.26
  • Krebs P, Norcross JC, Nicholson JM, Prochaska JO. Stages of change and psychotherapy outcomes: a review and meta-analysis. J Clin Psychol. 2018;74(11):1964–1979. doi:10.1002/jclp.22683
  • Linden M, Schermuly-Haupt ML. Definition, assessment and rate of psychotherapy side effects. World Psychiatry. 2014;13(3):306–309. doi:10.1002/wps.20153
  • Modlin NL, Miller TM, Rucker JJ, et al. Optimizing outcomes in psilocybin therapy: considerations in participant evaluation and preparation. J Affect Disord. 2023;326:18–25. doi:10.1016/j.jad.2023.01.077
  • Nijdam MJ, Vermetten E, McFarlane AC. Toward staging differentiation for posttraumatic stress disorder treatment. Acta Psychiatry Scand. 2023;147(1):65–80. doi:10.1111/acps.13520
  • Lewis C, Roberts NP, Gibson S, Bisson JI. Dropout from psychological therapies for post-traumatic stress disorder (PTSD) in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020;11(1):1709709. doi:10.1080/20008198.2019.1709709
  • D’Souza DC, Syed SA, Flynn LT, Safi-Aghdam H, Cozzi NV, Ranganathan M. Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder. Neuropsychopharmacology. 2022;47(10):1854–1862. doi:10.1038/s41386-022-01344-y
  • Lancelotta RL, Davis AK. Use of benefit enhancement strategies among 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) users: associations with mystical, challenging, and enduring effects. J Psychoactive Drugs. 2020;52(3):273–281. doi:10.1080/02791072.2020.1737763
  • Heal DJ, Gosden J, Smith SL, Atterwill CK. Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medications. Neuropharmacology. 2022;109375. doi:10.1016/j.neuropharm.2022.109375
  • Hogg B, Gardoki-Souto I, Valiente-Gómez A. Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2023;273(2):397–410. doi:10.1007/s00406-022-01495-5
  • Unwin G, Willott S, Hendrickson S, Stenfert Kroese B. Eye movement desensitization and reprocessing for adults with intellectual disabilities: Process issues from an acceptability study. J Appl Res Intellect Disabil. 2019;32(3):635–647.
  • Hendricks PS Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. Int Rev Psychiatry. 2018;30(4):331–342. doi:10.1080/09540261.2018.1474185